Table 3.
Laboratory data | Group 0 (n = 193) | Group 1 (n = 53) | Group 2 (n = 48) | Group 3 (n = 16) | p value |
---|---|---|---|---|---|
Hb (g/dL)* | 11.3 ± 1.4 | 11.5 ± 2.2 | 12.1 ± 2.0 | 10.6 ± 2.1 | 0.005 |
CRP > 0.8 mg/dL (%) | 38.5 | 47.2 | 38.3 | 68.8† | 0.09 |
CRP (mg/dL) | 0.9 ± 1.2 | 1.9 ± 2.6 | 1.7 ± 3.1 | 3.3 ± 4.8‡ | 0.001 |
Neutrophils (no/mm3)* | 4.424 ± 3.289 | 5.014 ± 3.646 | 4.416 ± 3.121 | 4.473 ± 3.771 | ns |
Lymphocytes (no/mm3)* | 5.642 ± 2.581 | 5.094 ± 2.817 | 4.417 ± 2.292 | 4.026 ± 2.260† | 0.004 |
Eosinophils (no/mm3)* | 152 ± 191 | 98 ± 99 | 105 ± 112 | 125 ± 323† | ns |
Glycemia (mg/dL)* | 103.5 ± 26.9 | 121.8 ± 47.4 | 114.8 ± 44.3 | 100.4 ± 16.2 | 0.004 |
Sodium (mEq/L)* | 137.9 ± 3.1 | 136.8 ± 3.1 | 136.5 ± 3.6 | 136.0 ± 4.1 | 0.006 |
Gamma‐glutamyl transpeptidase (U/L)* | 44.4 ± 37.0 | 43.2 ± 20.8 | 59.0 ± 52.6 | 65.4 ± 40.0 | 0.06 |
Aspartate aminotransferase (U/L)* | 41.0 ± 20.1 | 42.7 ± 36.9 | 38.6 ± 12.1 | 43.2 ± 25.1 | ns |
Alanine aminotransferase (U/L)* | 38.0 ± 24.3 | 34.2 ± 26.0 | 35.8 ± 15.7 | 41.5 ± 37.3 | ns |
*Mean ± SD of the worst condition observed.
p between groups.
†p < 0.05 group 3 vs groups 0, 1, 2.
‡p < 0.01 group 3 vs groups 0, 1, 2.